| Literature DB >> 35371636 |
Praveen K Baghel1, Sunil K Tripathi2, Althaf A Vahab1, Puneet Aggarwal3.
Abstract
Introduction We assessed the right ventricular function in patients with first acute anterior wall myocardial infarction (AWMI) and inferior wall myocardial infarction (IWMI) without associated right ventricular infarction and assessed the relation between right ventricular function and the in-hospital clinical outcomes. Methods The present study was an observational cross-sectional study, which enrolled a total of 200 patients with chest pain of <24 hours who were diagnosed with acute ST-segment elevation myocardial infarction (MI) for the first time. Echocardiography was performed with a special emphasis on the tricuspid annular plane systolic excursion (TAPSE) score. The in-hospital clinical outcomes include major adverse cardiac events (MACE), which refer to all-cause mortality, cardiovascular mortality, recurrent MI, heart failure, or stroke in patients with acute myocardial infarction (AMI). Results A total of 200 patients with AMI were enrolled in the study of which 66% were males. Of patients, 68% had AWMI and 32% had IWMI. Patients with AWMI had more right ventricular dysfunctional changes as compared to IWMI, as measured by TAPSE score (17.8 ± 4.64 mm vs. 19.87 ± 3.61; p = 0.01, respectively). The incidence of MACE was 27.9% in AWMI as compared to 12.5% in IWMI (41.9% vs. 18.75% had right ventricular dysfunction, respectively). The outcome of AWMI patients was poor as compared to IWMI patients, as measured by duration of hospital stay (9.5 ± 4.73 days and 6.6 ± 4.70 days, respectively) and mortality (17.64% in AWMI vs. 6.25% in IWMI). The patients of AMI with TAPSE score ≤18 mm, suggesting right ventricular dysfunction, had a higher rate of MACE compared to those with TAPSE score >18 mm, respectively, 36.23% vs. 12.2%. Conclusion From this study, it is concluded that AWMI results in a higher incidence of right ventricular dysfunction as compared to IWMI. Furthermore, patients with AMI with concomitant right ventricular dysfunction were found to have poorer outcomes in terms of longer duration of hospital stay, higher incidence of MACE, and higher mortality rate, as compared to patients of AMI without right ventricular dysfunction.Entities:
Keywords: anterior wall myocardial infarction; cardiovascular disease; inferior wall myocardial infarction; right ventricular function; tapse score
Year: 2022 PMID: 35371636 PMCID: PMC8938229 DOI: 10.7759/cureus.22399
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Baseline and demographic characteristics of all patients.
BP: blood pressure; JVP: jugular venous pressure.
| Characteristics | N (%) |
| Age, years (mean ± SD) | 56.01 ± 12.67 |
| 15-30 years, n (%) | 4 (2%) |
| 30-40 years, n (%) | 18 (9%) |
| 41-50 years, n (%) | 42 (21%) |
| 51-60 years, n (%) | 58 (29%) |
| 61-70 years, n (%) | 46 (23%) |
| >70 years, n (%) | 32 (16%) |
| Gender, n (%) | |
| Male | 132 (62%) |
| <50 years | 52 (39%) |
| ≥50 years | 80 (61%) |
| Female | 68 (38%) |
| <50 years | 12 (18%) |
| ≥50 years | 56 (82%) |
| Risk factors, n (%) | |
| Tobacco use | 82 (41%) |
| Alcohol | 64 (32%) |
| Systemic hypertension | 96 (48%) |
| Diabetes mellitus | 124 (62%) |
| Dyslipidemia | 88 (68%) |
| Symptoms, n (%) | |
| Chest pain | 136 (68%) |
| Breathlessness | 56 (28%) |
| Sweating | 48 (24%) |
| Palpitation | 24 (12%) |
| Syncope | 16 (8%) |
| Clinical signs, n (%) | |
| Pallor | 62 (31%) |
| Pulse <60/min | 38 (24%) |
| Pulse >100/min | 78 (39%) |
| BP <100 mmHg systolic | 64 (32%) |
| Elevated JVP | 24 (12%) |
| Pedal edema | 36 (18%) |
Clinical findings of all patients.
ECG: electrocardiography; TAPSE: tricuspid annular plane systolic excursion.
| Variables | N = 200 |
| ECG findings | |
| Septal wall | 8 (4%) |
| Anteroseptal wall | 64 (32%) |
| High lateral | 6 (3%) |
| Anterolateral wall | 42 (21%) |
| Extensive anterior wall | 16 (8%) |
| Inferior wall | 64 (32%) |
| Echocardiography (TAPSE score) | |
| >22 mm | 50 (25%) |
| 21-22 mm | 41 (20.5%) |
| 19-20 mm | 40 (20%) |
| 16-18 mm | 44 (22%) |
| <16 mm | 25 (12.5%) |
Heart rate, TAPSE score, and duration of hospital stay among AWMI and IWMI patients.
AWMI: anterior wall myocardial infarction; IWMI: inferior wall myocardial infarction; TAPSE: tricuspid annular plane systolic excursion.
| Variables | AWMI (n = 136) | IWMI (n = 64) | P-value |
| Heart rate | |||
| <60 bpm (bradycardia) | 16 (11.7%) | 14 (21.9%) | 0.001 |
| 60-100 bpm | 50 (36.8%) | 42 (65.6%) | |
| >100 bpm (tachycardia) | 70 (51.5%) | 8 (12.5%) | |
| TAPSE score, mm (mean ± SD) | 17.80 ± 4.64 | 19.87 ± 3.61 | 0.008 |
| >22 mm | 26 (19.1%) | 24 (37.5%) | |
| 21-22 mm | 25 (18.4%) | 16 (25%) | |
| 19-20 mm | 28 (20.6%) | 12 (18.7%) | |
| 16-18 mm | 36 (26.5%) | 8 (12.5%) | |
| <16 mm | 21 (15.4%) | 4 (6.25%) | |
| Duration of hospital stay, days (mean ± SD) | 9.5 ± 4.73 | 6.6 ± 4.70 | 0.0004 |
| ≤5 days | 26 (19.1%) | 30 (53.1%) | |
| 6-10 days | 56 (41.1%) | 22 (31.2%) | |
| 11-15 days | 38 (28%) | 8 (12.5%) | |
| >15 days | 16 (11.8%) | 4 (3.2%) |
Adverse events among patients with AWMI vs. IWMI.
AWMI: anterior wall myocardial infarction; IWMI: inferior wall myocardial infarction; MI: myocardial infarction; MACE: major adverse cardiac events.
| Adverse events | AWMI (n = 136) | IWMI (n = 64) | P-value |
| All-cause mortality | 24 (17.6%) | 4 (6.2%) | 0.032 |
| Cardiovascular mortality | 22 (1.5%) | 3 (4.7%) | 0.065 |
| Recurrent MI | 16 (11.7%) | 6 (9.4%) | 0.059 |
| Heart failure | 32 (23.5%) | 6 (9.4%) | 0.002 |
| Stroke | 6 (4.4%) | 00 | 0.013 |
| MACE | 38 (27.9%) | 8 (12.5%) | 0.034 |
| No complications | 98 (72%) | 56 (87.5%) | 0.345 |
Adverse events among patients with ≤18 mm vs. >18 mm TAPSE scores.
MI: myocardial infarction; MACE: major adverse cardiac events; TAPSE: tricuspid annular plane systolic excursion.
| Adverse events | TAPSE ≤ 18 mm (n = 69) | TAPSE > 18 mm (n = 131) | P-value |
| All-cause mortality | 18 (26.1%) | 10 (7.6%) | 0.023 |
| Cardiovascular mortality | 17 (24.6%) | 9 (6.9%) | 0.001 |
| Recurrent MI | 14 (20.3%) | 8 (6.1%) | 0.045 |
| Heart failure | 23 (33.3%) | 15 (11.4%) | 0.034 |
| Stroke | 4 (5.8%) | 2 (1.5%) | 0.004 |
| MACE | 25 (36.2%) | 16 (12.2%) | 0.030 |